uric acid has been researched along with Airflow Obstruction, Chronic in 39 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the correlation between the serum hypoxia-inducible factor-1α, uric acid, inflammatory factor levels, and lung function in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)." | 8.31 | Analysis of Correlation Between Serum Hypoxia-Inducible Factor-1α, Uric Acid, and Inflammatory Factor Levels and Lung Function in Patients with AECOPD. ( Deng, S; Gu, X; Lu, Q; Ma, X; Wang, C; Yang, Y; Zhang, J; Zhu, T, 2023) |
| "There are studies reporting that uric acid elevation is a marker for hypoxemia and pulmonary hypertension secondary to some diseases." | 8.02 | The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale. ( Güllü, YT; Güven Atici, A; Kir, E; Köksal, N; Tunçez, İH, 2021) |
| "The aim of this study was to test the hypothesis that pulmonary inflammation and emphysema induced by cadmium (Cd) inhalation are associated with pulmonary oxidative stress." | 7.73 | Airway inflammation in cadmium-exposed rats is associated with pulmonary oxidative stress and emphysema. ( Fievez, L; Gustin, P; Kirschvink, N; Marlin, D; Martin, N; Smith, N, 2006) |
| "To investigate the correlation between the serum hypoxia-inducible factor-1α, uric acid, inflammatory factor levels, and lung function in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)." | 4.31 | Analysis of Correlation Between Serum Hypoxia-Inducible Factor-1α, Uric Acid, and Inflammatory Factor Levels and Lung Function in Patients with AECOPD. ( Deng, S; Gu, X; Lu, Q; Ma, X; Wang, C; Yang, Y; Zhang, J; Zhu, T, 2023) |
| "There are studies reporting that uric acid elevation is a marker for hypoxemia and pulmonary hypertension secondary to some diseases." | 4.02 | The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale. ( Güllü, YT; Güven Atici, A; Kir, E; Köksal, N; Tunçez, İH, 2021) |
| "Our results suggest that the active production of uric acid from human airway epithelial cells may be intrinsically altered in asthma and be further induced by pro-inflammatory cytokines." | 3.85 | Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells. ( Hansbro, PM; Hirota, JA; Hsu, AC; Huff, RD; Jones, B; Knight, DA; Nichol, KS; Wark, PAB, 2017) |
| " We have investigated whether individual plasma antioxidant concentrations (uric acid and vitamins C, A, and E) and 10 antioxidant genes modify the response to PM with respect to hospital admissions for chronic obstructive pulmonary disease (COPD) or asthma." | 3.78 | PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics. ( Burney, P; Caneja, C; Canova, C; Dunster, C; Kelly, FJ; Minelli, C; Shah, PL; Tumilty, MK, 2012) |
| "The aim of this study was to test the hypothesis that pulmonary inflammation and emphysema induced by cadmium (Cd) inhalation are associated with pulmonary oxidative stress." | 3.73 | Airway inflammation in cadmium-exposed rats is associated with pulmonary oxidative stress and emphysema. ( Fievez, L; Gustin, P; Kirschvink, N; Marlin, D; Martin, N; Smith, N, 2006) |
| "Seven studies with 932 stable COPD patients and 401 healthy control subjects were included in this meta-analysis." | 2.72 | Serum uric acid level as a biomarker for chronic obstructive pulmonary disease: a meta-analysis. ( Chen, Y; Li, H, 2021) |
| "COPD is a major cause of morbidity and mortality worldwide and results in an economic and social burden that is both substantial and increasing." | 1.91 | Status of Serum Magnesium and Uric Acid in Patients with Chronic Obstructive Pulmonary Disease. ( Akhter, S; Faysal, MR; Hoque, MR; Krishna, SP; Momo, FR; Nessa, A; Saha, BK; Sarkar, S; Sultana, I, 2023) |
| "The Fried Frailty Symptom Scale was used to evaluate whether the 80 patients were complicated with frailty syndrome." | 1.72 | To Analyze the Influencing Factors of Senile Coronary Heart Disease Patients Complicated with Frailty Syndrome. ( Hu, G; Qin, T; Sheng, W, 2022) |
| "Chronic obstructive pulmonary disease (COPD) is presently the third major cause of death in the world with 80% of deaths due to COPD occurring in countries with low- and middle income." | 1.72 | Uric Acid : A Mirror to the Lungs in COPD. ( H, S; K, S, 2022) |
| "Among men with stable COPD, hyperuricemia is not an independent predictor of all-cause mortality or future acute exacerbation of COPD." | 1.56 | Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease. ( Hwang, JJ; Kim, EK; Kim, TH; Lee, JH; Lee, JS; Lee, SD; Lee, SW; Lim, SY; Oh, YM; Park, YB; Rhee, CK; Yoo, KH; Yoon, HI, 2020) |
| "Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, with oxidative stress and inflammation implicated in its development." | 1.56 | Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta. ( Čepelak, I; Hlapčić, I; Popović-Grle, S; Rako, I; Rogić, D; Rumora, L, 2020) |
| "The increased oxidative stress in chronic obstructive pulmonary disease (COPD) patients is the result of increased inhaled oxidants, generated by various cells of the airways." | 1.48 | Biomarkers of oxidative stress and protein-protein interaction in chronic obstructive pulmonary disease. ( Aggarwal, T; Maurya, PK; Rohil, V; Wadhwa, R, 2018) |
| "The under-diagnosis of COPD is very high." | 1.48 | Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors. ( Alsedà, M; Barbé, F; Betriu, À; Castañ, MT; Godoy, P; Lecube, A; Marsal, JR; Montserrat-Capdevila, J; Ortega, M; Portero, M; Pujol, J; Purroy, F; Seminario, MA; Valdivielso, JM, 2018) |
| "The prevalence of COPD and asthma is increasing all over the world; however, their morbidities are thought to be greatly underestimated because of unawareness of patients' conditions and respiratory symptoms." | 1.46 | The association between risk of airflow limitation and serum uric acid measured at medical health check-ups. ( Fukuhara, A; Fukuhara, N; Munakata, M; Rinno, K; Saito, J; Saito, K; Sato, S; Suzuki, H; Tanino, Y; Wang, X, 2017) |
| "RESULTS The study included 110 stable COPD patients and 52 healthy controls." | 1.43 | Serum Uric Acid Levels and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Parameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease? ( Aka Akturk, U; Akgun, M; Arinc, S; Boga, S; Durmus Kocak, N; Gungor, S; Sasak, G; Sengul, A, 2016) |
| "Consecutive COPD patients with intubation were screened at baseline." | 1.42 | Utility of uric acid as a risk marker of extubation success in chronic obstructive pulmonary disease. ( Du, YP; Huai, D; Niu, HY; Peng, YG; Shi, Y; Wan, YF; Xu, CQ; Zheng, DH; Zheng, YL, 2015) |
| "Patients with chronic obstructive pulmonary disease (COPD) are often at high risk of early death." | 1.42 | Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. ( Jin, S; Liang, R; Liu, L; Zhang, X, 2015) |
| "Uric acid levels were higher in patients with more severe airflow limitation and in those experiencing frequent exacerbations." | 1.40 | Serum uric acid as a predictor of mortality and future exacerbations of COPD. ( Bartziokas, K; Haniotou, A; Kostikas, K; Loukides, S; Papadopoulos, A; Papaioannou, AI; Papiris, S, 2014) |
| "CRP was significantly increased in the COPD patients with IC < 80% pred." | 1.37 | Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. ( Aliprandi, G; Fredi, M; Gatta, D; Pini, L; Tantucci, C; Zanardini, A, 2011) |
| "The salivary UA in COPD patients was 125% higher (p = 0." | 1.34 | Oxidative stress indices in COPD--Broncho-alveolar lavage and salivary analysis. ( Berkovich, Y; Nagler, RM; Yigla, M, 2007) |
| "Eleven patients with COPD and 11 healthy age-matched control subjects performed a maximal and submaximal exercise cycle ergometry test at 60% of peak workload." | 1.33 | Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. ( Akkermans, MA; Bast, A; Hageman, GJ; Mercken, EM; Schols, AM; Wouters, EF, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (25.64) | 29.6817 |
| 2010's | 17 (43.59) | 24.3611 |
| 2020's | 12 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, T | 1 |
| Sheng, W | 1 |
| Hu, G | 1 |
| Tanwar, Y | 1 |
| Singh, C | 1 |
| Chakrabarty, S | 1 |
| K, S | 1 |
| H, S | 1 |
| Dong, Y | 1 |
| Han, F | 1 |
| Su, Y | 1 |
| Sun, B | 1 |
| Zhao, W | 1 |
| Pan, C | 1 |
| Deng, S | 1 |
| Zhu, T | 1 |
| Wang, C | 1 |
| Gu, X | 1 |
| Zhang, J | 1 |
| Lu, Q | 1 |
| Yang, Y | 1 |
| Ma, X | 1 |
| Barmehziar, S | 1 |
| Fadaii, A | 1 |
| Samadian, F | 1 |
| Shakiba, A | 1 |
| Koolaji, S | 1 |
| Krishna, SP | 1 |
| Akhter, S | 1 |
| Nessa, A | 1 |
| Hoque, MR | 1 |
| Saha, BK | 1 |
| Faysal, MR | 1 |
| Sultana, I | 1 |
| Sarkar, S | 1 |
| Momo, FR | 1 |
| Hwang, JJ | 1 |
| Oh, YM | 1 |
| Rhee, CK | 1 |
| Yoo, KH | 1 |
| Park, YB | 1 |
| Yoon, HI | 1 |
| Lim, SY | 1 |
| Lee, JH | 1 |
| Kim, EK | 1 |
| Kim, TH | 1 |
| Lee, SW | 1 |
| Lee, SD | 1 |
| Lee, JS | 1 |
| Rumora, L | 1 |
| Hlapčić, I | 1 |
| Popović-Grle, S | 1 |
| Rako, I | 1 |
| Rogić, D | 1 |
| Čepelak, I | 1 |
| Wattanachayakul, P | 1 |
| Rujirachun, P | 1 |
| Charoenngam, N | 1 |
| Ungprasert, P | 1 |
| Li, H | 1 |
| Chen, Y | 1 |
| Kir, E | 1 |
| Güven Atici, A | 1 |
| Güllü, YT | 1 |
| Köksal, N | 1 |
| Tunçez, İH | 1 |
| Fukuhara, A | 1 |
| Saito, J | 1 |
| Sato, S | 1 |
| Saito, K | 1 |
| Fukuhara, N | 1 |
| Tanino, Y | 1 |
| Wang, X | 1 |
| Rinno, K | 1 |
| Suzuki, H | 1 |
| Munakata, M | 1 |
| Huff, RD | 1 |
| Hsu, AC | 1 |
| Nichol, KS | 1 |
| Jones, B | 1 |
| Knight, DA | 1 |
| Wark, PAB | 1 |
| Hansbro, PM | 1 |
| Hirota, JA | 1 |
| Aggarwal, T | 1 |
| Wadhwa, R | 1 |
| Rohil, V | 1 |
| Maurya, PK | 1 |
| Lee, H | 1 |
| Hong, Y | 1 |
| Lim, MN | 1 |
| Bak, SH | 1 |
| Kim, MJ | 1 |
| Kim, K | 1 |
| Kim, WJ | 1 |
| Park, HY | 1 |
| Kobylecki, CJ | 1 |
| Vedel-Krogh, S | 1 |
| Afzal, S | 1 |
| Nielsen, SF | 1 |
| Nordestgaard, BG | 1 |
| Montserrat-Capdevila, J | 1 |
| Seminario, MA | 1 |
| Godoy, P | 1 |
| Marsal, JR | 1 |
| Ortega, M | 1 |
| Pujol, J | 1 |
| Castañ, MT | 1 |
| Alsedà, M | 1 |
| Betriu, À | 1 |
| Lecube, A | 1 |
| Portero, M | 1 |
| Purroy, F | 1 |
| Valdivielso, JM | 1 |
| Barbé, F | 1 |
| Shaheen, SO | 1 |
| Kahnert, K | 1 |
| Alter, P | 1 |
| Welte, T | 1 |
| Huber, RM | 1 |
| Behr, J | 1 |
| Biertz, F | 1 |
| Watz, H | 1 |
| Bals, R | 1 |
| Vogelmeier, CF | 1 |
| Jörres, RA | 1 |
| Shibata, Y | 1 |
| Inoue, S | 1 |
| Watanabe, M | 1 |
| Bartziokas, K | 1 |
| Papaioannou, AI | 1 |
| Loukides, S | 1 |
| Papadopoulos, A | 1 |
| Haniotou, A | 1 |
| Papiris, S | 1 |
| Kostikas, K | 1 |
| Altay, S | 1 |
| Onat, A | 1 |
| Özpamuk-Karadeniz, F | 1 |
| Karadeniz, Y | 1 |
| Kemaloğlu-Öz, T | 1 |
| Can, G | 1 |
| Wan, YF | 1 |
| Zheng, YL | 1 |
| Du, YP | 1 |
| Huai, D | 1 |
| Peng, YG | 1 |
| Niu, HY | 1 |
| Xu, CQ | 1 |
| Shi, Y | 1 |
| Zheng, DH | 1 |
| Zhang, X | 1 |
| Liu, L | 1 |
| Liang, R | 1 |
| Jin, S | 1 |
| Durmus Kocak, N | 1 |
| Sasak, G | 1 |
| Aka Akturk, U | 1 |
| Akgun, M | 1 |
| Boga, S | 1 |
| Sengul, A | 1 |
| Gungor, S | 1 |
| Arinc, S | 1 |
| Mercken, EM | 2 |
| Calvert, LD | 1 |
| Singh, SJ | 1 |
| Hageman, GJ | 2 |
| Schols, AM | 2 |
| Steiner, MC | 1 |
| Nicks, ME | 1 |
| O'Brien, MM | 1 |
| Bowler, RP | 1 |
| Gatta, D | 1 |
| Aliprandi, G | 1 |
| Pini, L | 1 |
| Zanardini, A | 1 |
| Fredi, M | 1 |
| Tantucci, C | 1 |
| Canova, C | 1 |
| Dunster, C | 1 |
| Kelly, FJ | 1 |
| Minelli, C | 1 |
| Shah, PL | 1 |
| Caneja, C | 1 |
| Tumilty, MK | 1 |
| Burney, P | 1 |
| Kirschvink, N | 4 |
| Smith, N | 4 |
| Fiévez, L | 3 |
| Bougnet, V | 2 |
| Art, T | 3 |
| Degand, G | 2 |
| Marlin, D | 4 |
| Roberts, C | 3 |
| Génicot, B | 1 |
| Lindsey, P | 1 |
| Lekeux, P | 3 |
| de Moffarts, B | 1 |
| Harris, P | 1 |
| Sato, N | 1 |
| Kurashima, K | 1 |
| Ubukata, M | 1 |
| Takayanagi, N | 1 |
| Matsushima, H | 1 |
| Yanagisawa, T | 1 |
| Tokunaga, D | 1 |
| Sugita, Y | 1 |
| Kanazawa, M | 1 |
| Akkermans, MA | 1 |
| Bast, A | 1 |
| Wouters, EF | 1 |
| Martin, N | 1 |
| Gustin, P | 1 |
| Yigla, M | 1 |
| Berkovich, Y | 1 |
| Nagler, RM | 1 |
| Mazza, A | 1 |
| Zamboni, S | 1 |
| Tikhonoff, V | 1 |
| Scarpa, R | 1 |
| Cuppini, S | 1 |
| Zennaro, R | 1 |
| Pessina, AC | 1 |
| Casiglia, E | 1 |
| García Pachón, E | 1 |
| Padilla Navas, I | 1 |
| Shum, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Intervention Study to Assess the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease and Its Impact on Morbidity and Mortality: The ILERVAS Project[NCT03228459] | 16,660 participants (Actual) | Interventional | 2015-01-15 | Active, not recruiting | |||
| Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis and Utilisation of Health Care Resources in Patients With COPD[NCT01245933] | 2,741 participants (Actual) | Observational | 2010-11-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for uric acid and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis.
Topics: Biomarkers; Disease Progression; Dyspnea; Health Status; Humans; Pulmonary Disease, Chronic Obstruct | 2020 |
Serum uric acid level as a biomarker for chronic obstructive pulmonary disease: a meta-analysis.
Topics: Biomarkers; China; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Uric Acid | 2021 |
Impact of reduced pulmonary function in the Japanese general population: Lessons from the Yamagata-Takahata study.
Topics: Adiponectin; Asian People; Atrial Fibrillation; Biomarkers; Cigarette Smoking; Comorbidity; Diabetes | 2019 |
2 trials available for uric acid and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population.
Topics: Aged; Biomarkers; Denmark; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Predictiv | 2018 |
Effect of nutritional antioxidant supplementation on systemic and pulmonary antioxidant status, airway inflammation and lung function in heaves-affected horses.
Topics: Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Dietary Supplements; Dinoprost; Exercise Test; | 2002 |
34 other studies available for uric acid and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
To Analyze the Influencing Factors of Senile Coronary Heart Disease Patients Complicated with Frailty Syndrome.
Topics: Aged; Coronary Disease; Frail Elderly; Frailty; Humans; Interleukin-6; Natriuretic Peptide, Brain; P | 2022 |
Comparison of Serum Uric Acid Levels in Patients with Stable Chronic Obstructive Pulmonary Disease and Patients with Acute Exacerbation.
Topics: Creatinine; Cross-Sectional Studies; Humans; Hypoxia; Pulmonary Disease, Chronic Obstructive; Urea; | 2022 |
Uric Acid : A Mirror to the Lungs in COPD.
Topics: Adult; Aged; Aged, 80 and over; Bronchodilator Agents; Cross-Sectional Studies; Female; Forced Expir | 2022 |
High uric acid aggravates apoptosis of lung epithelial cells induced by cigarette smoke extract through downregulating PRDX2 in chronic obstructive pulmonary disease.
Topics: Animals; Antioxidants; Apoptosis; Cigarette Smoking; Epithelial Cells; Humans; Lung; Mice; Nicotiana | 2023 |
Analysis of Correlation Between Serum Hypoxia-Inducible Factor-1α, Uric Acid, and Inflammatory Factor Levels and Lung Function in Patients with AECOPD.
Topics: Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Pulmonary Disease, Chronic Obstruc | 2023 |
Investigating the role of uric acid and uric acid-to-creatinine ratio as a predictive factor of chronic obstructive pulmonary disease exacerbation in 2019.
Topics: Adult; Aged; Creatinine; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pulmonary Dis | 2023 |
Status of Serum Magnesium and Uric Acid in Patients with Chronic Obstructive Pulmonary Disease.
Topics: Bangladesh; Case-Control Studies; Cross-Sectional Studies; Humans; Magnesium; Pulmonary Disease, Chr | 2023 |
Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease.
Topics: Aged; Female; Humans; Hyperuricemia; Kaplan-Meier Estimate; Lung; Lymphocytes; Male; Middle Aged; Ne | 2020 |
Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Creatinine; Cytokines; Female; Fibrinogen; | 2020 |
The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale.
Topics: Creatinine; Humans; Hypertension, Pulmonary; Pulmonary Disease, Chronic Obstructive; Pulmonary Heart | 2021 |
The association between risk of airflow limitation and serum uric acid measured at medical health check-ups.
Topics: Adult; Aged; Asthma; Biomarkers; Female; Forced Expiratory Volume; Humans; Hyperuricemia; Japan; Log | 2017 |
Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells.
Topics: Adult; Aged; Allergens; Animals; Asthma; Bronchi; Cells, Cultured; Disease Models, Animal; Epithelia | 2017 |
Biomarkers of oxidative stress and protein-protein interaction in chronic obstructive pulmonary disease.
Topics: Ascorbic Acid; Case-Control Studies; Female; Gene Expression Regulation, Enzymologic; Humans; Male; | 2018 |
Inflammatory biomarkers and radiologic measurements in never-smokers with COPD: A cross-sectional study from the CODA cohort.
Topics: Aged; Bilirubin; C-Reactive Protein; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; | 2018 |
Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors.
Topics: Age Factors; Aged; Cardiovascular Diseases; Female; Glycated Hemoglobin; Humans; Logistic Models; Ma | 2018 |
Uric acid, lung function and COPD: a causal link is unlikely.
Topics: Humans; Pulmonary Disease, Chronic Obstructive; Respiratory Physiological Phenomena; Uric Acid | 2018 |
Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.
Topics: Aged; Biomarkers; Comorbidity; Cross-Sectional Studies; Exercise; Female; Forced Expiratory Flow Rat | 2018 |
Serum uric acid as a predictor of mortality and future exacerbations of COPD.
Topics: Aged; Biomarkers; Cohort Studies; Disease Progression; Female; Hospitalization; Humans; Length of St | 2014 |
Renal "hyperfiltrators" are at elevated risk of death and chronic diseases.
Topics: Adult; Aged; Autoimmunity; Blood Pressure; Body Mass Index; Cause of Death; Cholesterol, LDL; Chroni | 2014 |
Utility of uric acid as a risk marker of extubation success in chronic obstructive pulmonary disease.
Topics: Aged; Airway Extubation; Biomarkers; Clinical Laboratory Techniques; Critical Care; Female; Humans; | 2015 |
Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Biomarkers; Chi-Square Distribution; Female; Humans; Hyperuricemia; Kaplan-Meier Estima | 2015 |
Serum Uric Acid Levels and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Parameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease?
Topics: Aged; Case-Control Studies; Creatinine; Disease Progression; Female; Humans; Male; Middle Aged; Pulm | 2016 |
Dichloroacetate modulates the oxidative stress and inflammatory response to exercise in COPD.
Topics: Aged; Biomarkers; Body Composition; Cross-Over Studies; Dichloroacetic Acid; Double-Blind Method; Ex | 2009 |
Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers.
Topics: Aged; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Colorado; Colorimetry; Cros | 2011 |
Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Topics: Aged; Alpha-Globulins; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Female; Forced Expir | 2011 |
PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Antioxidants; Asthma; Biomarkers; Case-Contr | 2012 |
Effect of chronic airway inflammation and exercise on pulmonary and systemic antioxidant status of healthy and heaves-affected horses.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chronic Disease; Dinoprost; F2-Isoprostanes; Glutathione; Glu | 2002 |
Relationship between markers of blood oxidant status and physiological variables in healthy and heaves-affected horses after exercise.
Topics: Animals; Antioxidants; Biomarkers; Blood Gas Analysis; Dinoprost; Exercise Test; F2-Isoprostanes; Gl | 2002 |
[Prognostic significance of serum uric acid in patients with chronic obstructive pulmonary disease receiving home oxygen therapy].
Topics: Adult; Aged; Creatinine; Female; Home Care Services; Humans; Male; Middle Aged; Oxygen Inhalation Th | 2003 |
Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease.
Topics: Breath Tests; Case-Control Studies; Comet Assay; DNA Damage; Exercise Test; Exercise Therapy; Exerci | 2005 |
Airway inflammation in cadmium-exposed rats is associated with pulmonary oxidative stress and emphysema.
Topics: Animals; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Cadmium; Dinoprost; Glutathione; | 2006 |
Oxidative stress indices in COPD--Broncho-alveolar lavage and salivary analysis.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Antioxidants; Bronchoalveolar Lavage Fluid; Fema | 2007 |
Pulse hypertension: a new component of the metabolic syndrome in elderly women?
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Blood Glucose; Blood Pressure; Coronary Disease; Cr | 2007 |
[Uric acid and its relationship to creatinine levels and hypoxia].
Topics: Creatinine; Humans; Hypoxia; Pulmonary Disease, Chronic Obstructive; Uric Acid | 2007 |